English

Guardion Health Sciences, Inc.

EDGAR

GHSI Quarterly report (10-Q) · filed 2024-08-13

44 filing records in this dataset, filed from 2016-02-11 to 2024-08-13. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

72.9 thousand USD

2024 Q2 · USD

Exact inputs and evidence

Revenue: 72918 USD Source

Operating margin

-1,894.36%

2024 Q2 · %

Exact inputs and evidence

Operating Income: -1381326 USD Source
Revenue: 72918 USD Source

Operating cash flow

-1.08 million USD

2024 Q2 · USD

Exact inputs and evidence

Operating Cash Flow: -1834766 USD Source
Operating Cash Flow: -754611 USD Source

Cash and cash equivalents: 14.8 million USD 2024-06-30 Source
Exact value

14822826 USD
Long-term debt including current maturities: Not available
Shares outstanding: 1.28 million shares 2024-06-30 Source
Exact value

1284156 shares

Reported share-count change

1.33% · 16.8 thousand shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

1267340 shares · 2023-06-30· Source
1284156 shares · 2024-06-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

9.35 million USD

2023-07-01 – 2024-06-30

Exact inputs and evidence

Revenue: 3337190 USD · 2023-07-01 – 2023-09-30 Source
Revenue: 12248550 USD · 2023-01-01 – 2023-12-31 Source
Revenue: 9312695 USD · 2023-01-01 – 2023-09-30 Source
Revenue: 2999645 USD · 2024-01-01 – 2024-03-31 Source
Revenue: 72918 USD · 2024-04-01 – 2024-06-30 Source

Net income

6.37 million USD

2023-07-01 – 2024-06-30

Exact inputs and evidence

Net income: 372633 USD · 2023-07-01 – 2023-09-30 Source
Net income: 158033 USD · 2023-01-01 – 2023-12-31 Source
Net income: -266687 USD · 2023-01-01 – 2023-09-30 Source
Net income: -4746744 USD · 2024-01-01 – 2024-03-31 Source
Net income: 10324330 USD · 2024-04-01 – 2024-06-30 Source

Operating cash flow

-3.92 million USD

2023-07-01 – 2024-06-30

Exact inputs and evidence

Operating cash flow: -3052293 USD · 2023-01-01 – 2023-09-30 Source
Operating cash flow: -2285712 USD · 2023-01-01 – 2023-06-30 Source
Operating cash flow: -4369885 USD · 2023-01-01 – 2023-12-31 Source
Operating cash flow: -3052293 USD · 2023-01-01 – 2023-09-30 Source
Operating cash flow: -754611 USD · 2024-01-01 – 2024-03-31 Source
Operating cash flow: -1834766 USD · 2024-01-01 – 2024-06-30 Source
Operating cash flow: -754611 USD · 2024-01-01 – 2024-03-31 Source

Capital expenditure

3.79 thousand USD

2023-01-01 – 2023-12-31

Exact inputs and evidence

Capital expenditure: 1654 USD · 2023-01-01 – 2023-03-31 Source
Capital expenditure: 3791 USD · 2023-01-01 – 2023-06-30 Source
Capital expenditure: 1654 USD · 2023-01-01 – 2023-03-31 Source
Capital expenditure: 3791 USD · 2023-01-01 – 2023-09-30 Source
Capital expenditure: 3791 USD · 2023-01-01 – 2023-06-30 Source
Capital expenditure: 3792 USD · 2023-01-01 – 2023-12-31 Source
Capital expenditure: 3791 USD · 2023-01-01 – 2023-09-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2024-08-13.

Financial data available through: 2023-12-31.

Coverage by financial measure

Revenue: 9 of 11 periods available· newest 2023-12-31
Operating income: 9 of 11 periods available· newest 2023-12-31
Net income: 9 of 11 periods available· newest 2023-12-31
Operating cash flow: 9 of 11 periods available· newest 2023-12-31
Capital expenditure: 9 of 11 periods available· newest 2023-12-31
Total assets: 9 of 11 periods available· newest 2023-12-31
Total liabilities: 8 of 11 periods available· newest 2023-12-31
Current assets: 9 of 11 periods available· newest 2023-12-31
Current liabilities: 9 of 11 periods available· newest 2023-12-31
Cash and cash equivalents: 9 of 11 periods available· newest 2023-12-31
long term debt: No compatible figures in this window
Shares outstanding: 9 of 11 periods available· newest 2023-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+10.8%

Prior period

USD 11.05 million

2022-01-01 – 2022-12-31
Current period

USD 12.25 million

2023-01-01 – 2023-12-31

Exact inputs and evidence

12248550 − 11049772 = 1198778 USD

11049772 USD · 2022-01-01 – 2022-12-31
Inspect prior input Prior source
12248550 USD · 2023-01-01 – 2023-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · Guardion Health Sciences, Inc. · 2023-12-31 Guardion Health Sciences, Inc. (edgar:1642375) Year-over-year change in Revenue: 1198778 USD Concept: fundies:Revenue Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T18:04:48Z Snapshot: fee39ab9da2ec6e0d64b11ac4212a48b5c028adf2a50ce0efb49b877ab2b1e6a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1642375?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 12248550 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1642375/000149315224011813/form10-k.htm#1095317 Filing: 000149315224011813 Input fundies:Revenue: 11049772 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1642375/000149315224011813/form10-k.htm#1095790 Filing: 000149315224011813
The citation records this snapshot. The page link may show a newer release later.
Net income
+USD 15.08 million

Prior period

−USD 14.92 million

2022-01-01 – 2022-12-31
Current period

USD 158,033

2023-01-01 – 2023-12-31

Exact inputs and evidence

158033 − -14922228 = 15080261 USD

-14922228 USD · 2022-01-01 – 2022-12-31
Inspect prior input Prior source
158033 USD · 2023-01-01 – 2023-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · Guardion Health Sciences, Inc. · 2023-12-31 Guardion Health Sciences, Inc. (edgar:1642375) Year-over-year change in Net income: 15080261 USD Concept: fundies:NetIncome Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T18:04:48Z Snapshot: fee39ab9da2ec6e0d64b11ac4212a48b5c028adf2a50ce0efb49b877ab2b1e6a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1642375?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: 158033 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1642375/000149315224011813/form10-k.htm#946982 Filing: 000149315224011813 Input fundies:NetIncome: -14922228 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1642375/000149315224011813/form10-k.htm#947836 Filing: 000149315224011813
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 3.08 million

Prior period

−USD 7.45 million

2022-01-01 – 2022-12-31
Current period

−USD 4.37 million

2023-01-01 – 2023-12-31

Exact inputs and evidence

-4369885 − -7446812 = 3076927 USD

-7446812 USD · 2022-01-01 – 2022-12-31
Inspect prior input Prior source
-4369885 USD · 2023-01-01 – 2023-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · Guardion Health Sciences, Inc. · 2023-12-31 Guardion Health Sciences, Inc. (edgar:1642375) Year-over-year change in Operating cash flow: 3076927 USD Concept: fundies:OperatingCashFlow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T18:04:48Z Snapshot: fee39ab9da2ec6e0d64b11ac4212a48b5c028adf2a50ce0efb49b877ab2b1e6a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1642375?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -4369885 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1642375/000149315224011813/form10-k.htm#1053391 Filing: 000149315224011813 Input fundies:OperatingCashFlow: -7446812 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1642375/000149315224011813/form10-k.htm#990003 Filing: 000149315224011813
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-31.9%

Prior period

USD 5,569

2022-01-01 – 2022-12-31
Current period

USD 3,792

2023-01-01 – 2023-12-31

Exact inputs and evidence

3792 − 5569 = -1777 USD

5569 USD · 2022-01-01 – 2022-12-31
Inspect prior input Prior source
3792 USD · 2023-01-01 – 2023-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · Guardion Health Sciences, Inc. · 2023-12-31 Guardion Health Sciences, Inc. (edgar:1642375) Year-over-year change in Capital expenditure: -1777 USD Concept: fundies:CapitalExpenditure Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T18:04:48Z Snapshot: fee39ab9da2ec6e0d64b11ac4212a48b5c028adf2a50ce0efb49b877ab2b1e6a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1642375?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 3792 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1642375/000149315224011813/form10-k.htm#994524 Filing: 000149315224011813 Input fundies:CapitalExpenditure: 5569 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1642375/000149315224011813/form10-k.htm#995360 Filing: 000149315224011813
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2023 2023-01-01 – 2023-12-31

Revenue USD 12.25 million 100% of revenue
Cost of revenue USD 6.85 million 56% of revenue
Operating expenses USD 9.73 million 79% of revenue
Operating income −USD 4.34 million −35% of revenue
Tax, interest and other Derived −USD 4.49 million −37% of revenue
Net income USD 158,033 1.3% of revenue

Cash

Operating cash flow −USD 4.37 million −36% of revenue
Capital expenditure USD 3,792 0% of revenue
Free cash flow Derived −USD 4.37 million −36% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2015 Operating loss: operating costs were 5,763% of revenue.
2016 Operating loss: operating costs were 2,898% of revenue.
2017 Operating loss: operating costs were 1,308% of revenue.
2018 Operating loss: operating costs were 752% of revenue.
2019 Operating loss: operating costs were 1,263% of revenue.
2020 Operating loss: operating costs were 553% of revenue.
2021 Operating loss: operating costs were 442% of revenue.
2022 Operating loss: operating costs were 258% of revenue.
2023 Operating loss: operating costs were 135% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2015 2015-01-01 – 2015-12-31	112811	6501550 Derived	-6388739	2452557 Derived	-8841296	-1141920 Derived	Source 2015-01-01 – 2015-12-31: 112811 USD Inspect Revenue Open source 2015-01-01 – 2015-12-31: -6388739 USD Inspect Operating Income Open source 2015-01-01 – 2015-12-31: -8841296 USD Inspect Net Income Open source 2015-01-01 – 2015-12-31: -1139758 USD Inspect Operating Cash Flow Open source 2015-01-01 – 2015-12-31: 2162 USD Inspect Capital Expenditure Open source
2016 2016-01-01 – 2016-12-31	141029	4086722 Derived	-3945693	1802704 Derived	-5748397	-1656928 Derived	Source 2016-01-01 – 2016-12-31: 141029 USD Inspect Revenue Open source 2016-01-01 – 2016-12-31: -3945693 USD Inspect Operating Income Open source 2016-01-01 – 2016-12-31: -5748397 USD Inspect Net Income Open source 2016-01-01 – 2016-12-31: -1653574 USD Inspect Operating Cash Flow Open source 2016-01-01 – 2016-12-31: 3354 USD Inspect Capital Expenditure Open source
2017 2017-01-01 – 2017-12-31	437349	5718791 Derived	-5281442	23727 Derived	-5305169	-3440976 Derived	Source 2017-01-01 – 2017-12-31: 437349 USD Inspect Revenue Open source 2017-01-01 – 2017-12-31: -5281442 USD Inspect Operating Income Open source 2017-01-01 – 2017-12-31: -5305169 USD Inspect Net Income Open source 2017-01-01 – 2017-12-31: -3403696 USD Inspect Operating Cash Flow Open source 2017-01-01 – 2017-12-31: 37280 USD Inspect Capital Expenditure Open source
2018 2018-01-01 – 2018-12-31	942153	7085874 Derived	-6143721	1623686 Derived	-7767407	-4434074 Derived	Source 2018-01-01 – 2018-12-31: 942153 USD Inspect Revenue Open source 2018-01-01 – 2018-12-31: -6143721 USD Inspect Operating Income Open source 2018-01-01 – 2018-12-31: -7767407 USD Inspect Net Income Open source 2018-01-01 – 2018-12-31: -4173831 USD Inspect Operating Cash Flow Open source 2018-01-01 – 2018-12-31: 260243 USD Inspect Capital Expenditure Open source
2019 2019-01-01 – 2019-12-31	902937	11399874 Derived	-10496937	381371 Derived	-10878308	-6201080 Derived	Source 2019-01-01 – 2019-12-31: 902937 USD Inspect Revenue Open source 2019-01-01 – 2019-12-31: -10496937 USD Inspect Operating Income Open source 2019-01-01 – 2019-12-31: -10878308 USD Inspect Net Income Open source 2019-01-01 – 2019-12-31: -6030004 USD Inspect Operating Cash Flow Open source 2019-01-01 – 2019-12-31: 171076 USD Inspect Capital Expenditure Open source
2020 2020-01-01 – 2020-12-31	1889844	10441575 Derived	-8551731	19926 Derived	-8571657	-8054662 Derived	Source 2020-01-01 – 2020-12-31: 1889844 USD Inspect Revenue Open source 2020-01-01 – 2020-12-31: -8551731 USD Inspect Operating Income Open source 2020-01-01 – 2020-12-31: -8571657 USD Inspect Net Income Open source 2020-01-01 – 2020-12-31: -8013929 USD Inspect Operating Cash Flow Open source 2020-01-01 – 2020-12-31: 40733 USD Inspect Capital Expenditure Open source
2021 2021-01-01 – 2021-12-31	7233118	31979924 Derived	-24746806	-1797 Derived	-24745009	-10719008 Derived	Source 2021-01-01 – 2021-12-31: 7233118 USD Inspect Revenue Open source 2021-01-01 – 2021-12-31: -24746806 USD Inspect Operating Income Open source 2021-01-01 – 2021-12-31: -24745009 USD Inspect Net Income Open source 2021-01-01 – 2021-12-31: -10644416 USD Inspect Operating Cash Flow Open source 2021-01-01 – 2021-12-31: 74592 USD Inspect Capital Expenditure Open source
2022 2022-01-01 – 2022-12-31	11049772	28470370 Derived	-17420598	-2498370 Derived	-14922228	-7452381 Derived	Source 2022-01-01 – 2022-12-31: 11049772 USD Inspect Revenue Open source 2022-01-01 – 2022-12-31: -17420598 USD Inspect Operating Income Open source 2022-01-01 – 2022-12-31: -14922228 USD Inspect Net Income Open source 2022-01-01 – 2022-12-31: -7446812 USD Inspect Operating Cash Flow Open source 2022-01-01 – 2022-12-31: 5569 USD Inspect Capital Expenditure Open source
2023 2023-01-01 – 2023-12-31	12248550	16584867 Derived	-4336317	-4494350 Derived	158033	-4373677 Derived	Source 2023-01-01 – 2023-12-31: 12248550 USD Inspect Revenue Open source 2023-01-01 – 2023-12-31: -4336317 USD Inspect Operating Income Open source 2023-01-01 – 2023-12-31: 158033 USD Inspect Net Income Open source 2023-01-01 – 2023-12-31: -4369885 USD Inspect Operating Cash Flow Open source 2023-01-01 – 2023-12-31: 3792 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 12.2M 2023

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20152015-12-31	Revenue	112811	Revenue: 112811 Open source
20162016-12-31	Revenue	141029	Revenue: 141029 Open source
20172017-12-31	Revenue	437349	Revenue: 437349 Open source
20182018-12-31	Revenue	942153	Revenue: 942153 Open source
20192019-12-31	Revenue	902937	Revenue: 902937 Open source
20202020-12-31	Revenue	1889844	Revenue: 1889844 Open source
20212021-12-31	Revenue	7233118	Revenue: 7233118 Open source
20222022-12-31	Revenue	11049772	Revenue: 11049772 Open source
20232023-12-31	Revenue	12248550	Revenue: 12248550 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

10.8% 2023

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20152015-12-31	Year over year	No prior comparable period	Revenue: 112811 Open source
20162016-12-31	Year over year	25%	Revenue: 141029 Open source Revenue: 112811 Open source
20172017-12-31	Year over year	210.1%	Revenue: 437349 Open source Revenue: 141029 Open source
20182018-12-31	Year over year	115.4%	Revenue: 942153 Open source Revenue: 437349 Open source
20192019-12-31	Year over year	-4.2%	Revenue: 902937 Open source Revenue: 942153 Open source
20202020-12-31	Year over year	109.3%	Revenue: 1889844 Open source Revenue: 902937 Open source
20212021-12-31	Year over year	282.7%	Revenue: 7233118 Open source Revenue: 1889844 Open source
20222022-12-31	Year over year	52.8%	Revenue: 11049772 Open source Revenue: 7233118 Open source
20232023-12-31	Year over year	10.8%	Revenue: 12248550 Open source Revenue: 11049772 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -35.4% 2023

Net margin 1.3% 2023

Free cash flow margin -35.7% 2023

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20152015-12-31	Operating margin	-5,663.2%	Operating Income: -6388739 Open source Revenue: 112811 Open source
20162016-12-31	Operating margin	-2,797.8%	Operating Income: -3945693 Open source Revenue: 141029 Open source
20172017-12-31	Operating margin	-1,207.6%	Operating Income: -5281442 Open source Revenue: 437349 Open source
20182018-12-31	Operating margin	-652.1%	Operating Income: -6143721 Open source Revenue: 942153 Open source
20192019-12-31	Operating margin	-1,162.5%	Operating Income: -10496937 Open source Revenue: 902937 Open source
20202020-12-31	Operating margin	-452.5%	Operating Income: -8551731 Open source Revenue: 1889844 Open source
20212021-12-31	Operating margin	-342.1%	Operating Income: -24746806 Open source Revenue: 7233118 Open source
20222022-12-31	Operating margin	-157.7%	Operating Income: -17420598 Open source Revenue: 11049772 Open source
20232023-12-31	Operating margin	-35.4%	Operating Income: -4336317 Open source Revenue: 12248550 Open source
20152015-12-31	Net margin	-7,837.3%	Net Income: -8841296 Open source Revenue: 112811 Open source
20162016-12-31	Net margin	-4,076%	Net Income: -5748397 Open source Revenue: 141029 Open source
20172017-12-31	Net margin	-1,213%	Net Income: -5305169 Open source Revenue: 437349 Open source
20182018-12-31	Net margin	-824.4%	Net Income: -7767407 Open source Revenue: 942153 Open source
20192019-12-31	Net margin	-1,204.8%	Net Income: -10878308 Open source Revenue: 902937 Open source
20202020-12-31	Net margin	-453.6%	Net Income: -8571657 Open source Revenue: 1889844 Open source
20212021-12-31	Net margin	-342.1%	Net Income: -24745009 Open source Revenue: 7233118 Open source
20222022-12-31	Net margin	-135%	Net Income: -14922228 Open source Revenue: 11049772 Open source
20232023-12-31	Net margin	1.3%	Net Income: 158033 Open source Revenue: 12248550 Open source
20152015-12-31	Free cash flow margin	-1,012.2%	Revenue: 112811 Open source Operating Cash Flow: -1139758 Open source Capital Expenditure: 2162 Open source
20162016-12-31	Free cash flow margin	-1,174.9%	Revenue: 141029 Open source Operating Cash Flow: -1653574 Open source Capital Expenditure: 3354 Open source
20172017-12-31	Free cash flow margin	-786.8%	Revenue: 437349 Open source Operating Cash Flow: -3403696 Open source Capital Expenditure: 37280 Open source
20182018-12-31	Free cash flow margin	-470.6%	Revenue: 942153 Open source Operating Cash Flow: -4173831 Open source Capital Expenditure: 260243 Open source
20192019-12-31	Free cash flow margin	-686.8%	Revenue: 902937 Open source Operating Cash Flow: -6030004 Open source Capital Expenditure: 171076 Open source
20202020-12-31	Free cash flow margin	-426.2%	Revenue: 1889844 Open source Operating Cash Flow: -8013929 Open source Capital Expenditure: 40733 Open source
20212021-12-31	Free cash flow margin	-148.2%	Revenue: 7233118 Open source Operating Cash Flow: -10644416 Open source Capital Expenditure: 74592 Open source
20222022-12-31	Free cash flow margin	-67.4%	Revenue: 11049772 Open source Operating Cash Flow: -7446812 Open source Capital Expenditure: 5569 Open source
20232023-12-31	Free cash flow margin	-35.7%	Revenue: 12248550 Open source Operating Cash Flow: -4369885 Open source Capital Expenditure: 3792 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -4.4M 2023

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20152015-12-31	Operating cash flow	-1139758	Operating Cash Flow: -1139758 Open source
20162016-12-31	Operating cash flow	-1653574	Operating Cash Flow: -1653574 Open source
20172017-12-31	Operating cash flow	-3403696	Operating Cash Flow: -3403696 Open source
20182018-12-31	Operating cash flow	-4173831	Operating Cash Flow: -4173831 Open source
20192019-12-31	Operating cash flow	-6030004	Operating Cash Flow: -6030004 Open source
20202020-12-31	Operating cash flow	-8013929	Operating Cash Flow: -8013929 Open source
20212021-12-31	Operating cash flow	-10644416	Operating Cash Flow: -10644416 Open source
20222022-12-31	Operating cash flow	-7446812	Operating Cash Flow: -7446812 Open source
20232023-12-31	Operating cash flow	-4369885	Operating Cash Flow: -4369885 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -4.4M 2023

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20152015-12-31	Free cash flow	-1141920	Operating Cash Flow: -1139758 Open source Capital Expenditure: 2162 Open source
20162016-12-31	Free cash flow	-1656928	Operating Cash Flow: -1653574 Open source Capital Expenditure: 3354 Open source
20172017-12-31	Free cash flow	-3440976	Operating Cash Flow: -3403696 Open source Capital Expenditure: 37280 Open source
20182018-12-31	Free cash flow	-4434074	Operating Cash Flow: -4173831 Open source Capital Expenditure: 260243 Open source
20192019-12-31	Free cash flow	-6201080	Operating Cash Flow: -6030004 Open source Capital Expenditure: 171076 Open source
20202020-12-31	Free cash flow	-8054662	Operating Cash Flow: -8013929 Open source Capital Expenditure: 40733 Open source
20212021-12-31	Free cash flow	-10719008	Operating Cash Flow: -10644416 Open source Capital Expenditure: 74592 Open source
20222022-12-31	Free cash flow	-7452381	Operating Cash Flow: -7446812 Open source Capital Expenditure: 5569 Open source
20232023-12-31	Free cash flow	-4373677	Operating Cash Flow: -4369885 Open source Capital Expenditure: 3792 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

31.7% 2023

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20152015-12-31	Liabilities / assets	599.5%	Total Liabilities: 1473314 Open source Total Assets: 245764 Open source
20162016-12-31	Liabilities / assets	231.9%	Total Liabilities: 607619 Open source Total Assets: 262045 Open source
2017-12-31	Liabilities / assets	Not reported	Total Assets: 7370223 Open source
20182018-12-31	Liabilities / assets	13.5%	Total Liabilities: 495337 Open source Total Assets: 3681100 Open source
20192019-12-31	Liabilities / assets	6.6%	Total Liabilities: 844981 Open source Total Assets: 12876821 Open source
20202020-12-31	Liabilities / assets	13.6%	Total Liabilities: 1345634 Open source Total Assets: 9860900 Open source
20212021-12-31	Liabilities / assets	5%	Total Liabilities: 1162852 Open source Total Assets: 23460652 Open source
20222022-12-31	Liabilities / assets	39.3%	Total Liabilities: 8518146 Open source Total Assets: 21686068 Open source
20232023-12-31	Liabilities / assets	31.7%	Total Liabilities: 3772134 Open source Total Assets: 11918177 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

9.01× 2023

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20152015-12-31	Current assets / current liabilities	0.07×	Current Assets: 64499 Open source Current Liabilities: 956739 Open source
20162016-12-31	Current assets / current liabilities	0.23×	Current Assets: 137555 Open source Current Liabilities: 607619 Open source
20172017-12-31	Current assets / current liabilities	10.16×	Current Assets: 5079895 Open source Current Liabilities: 499947 Open source
20182018-12-31	Current assets / current liabilities	2.23×	Current Assets: 1104921 Open source Current Liabilities: 495337 Open source
20192019-12-31	Current assets / current liabilities	28.93×	Current Assets: 11867718 Open source Current Liabilities: 410234 Open source
20202020-12-31	Current assets / current liabilities	8.47×	Current Assets: 9094883 Open source Current Liabilities: 1073731 Open source
20212021-12-31	Current assets / current liabilities	10.41×	Current Assets: 12069184 Open source Current Liabilities: 1159045 Open source
20222022-12-31	Current assets / current liabilities	5.39×	Current Assets: 21637197 Open source Current Liabilities: 4011546 Open source
20232023-12-31	Current assets / current liabilities	9.01×	Current Assets: 11884932 Open source Current Liabilities: 1319034 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2015 2015-01-01 – 2015-12-31	−USD 8.84 million Exact value Exact value: -8841296 USD 2015-01-01 – 2015-12-31: -8841296 USD Inspect Net Income Open source Share or cite Citation for Net Income · Guardion Health Sciences, Inc. · 2015-12-31 Guardion Health Sciences, Inc. (edgar:1642375) Net Income: -8841296 USD Concept: fundies:NetIncome Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T18:04:48Z Snapshot: fee39ab9da2ec6e0d64b11ac4212a48b5c028adf2a50ce0efb49b877ab2b1e6a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1642375/explain?concept=fundies%3ANetIncome&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:NetIncome: -8841296 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1642375/000114420417017714/cik0001642375-20161231.xml#140350 Filing: 000114420417017714 The citation records this snapshot. The page link may show a newer release later.	−USD 1.14 million Exact value Exact value: -1139758 USD 2015-01-01 – 2015-12-31: -1139758 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Guardion Health Sciences, Inc. · 2015-12-31 Guardion Health Sciences, Inc. (edgar:1642375) Operating Cash Flow: -1139758 USD Concept: fundies:OperatingCashFlow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T18:04:48Z Snapshot: fee39ab9da2ec6e0d64b11ac4212a48b5c028adf2a50ce0efb49b877ab2b1e6a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1642375/explain?concept=fundies%3AOperatingCashFlow&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1139758 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1642375/000114420417017714/cik0001642375-20161231.xml#145160 Filing: 000114420417017714 The citation records this snapshot. The page link may show a newer release later.	USD 2,162 Exact value Exact value: 2162 USD 2015-01-01 – 2015-12-31: 2162 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Guardion Health Sciences, Inc. · 2015-12-31 Guardion Health Sciences, Inc. (edgar:1642375) Capital Expenditure: 2162 USD Concept: fundies:CapitalExpenditure Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T18:04:48Z Snapshot: fee39ab9da2ec6e0d64b11ac4212a48b5c028adf2a50ce0efb49b877ab2b1e6a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1642375/explain?concept=fundies%3ACapitalExpenditure&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2162 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1642375/000114420417017714/cik0001642375-20161231.xml#145590 Filing: 000114420417017714 The citation records this snapshot. The page link may show a newer release later.	−USD 1.14 million Calculation and evidence -1139758 − 2162 USD Exact free cash flow: -1141920 USD 2015-01-01 – 2015-12-31: -1139758 USD · Inspect Operating Cash Flow · Source 2015-01-01 – 2015-12-31: 2162 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Guardion Health Sciences, Inc. · 2015-12-31 Guardion Health Sciences, Inc. (edgar:1642375) Free cash flow: -1141920 USD Concept: free-cash-flow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T18:04:48Z Snapshot: fee39ab9da2ec6e0d64b11ac4212a48b5c028adf2a50ce0efb49b877ab2b1e6a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1642375?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -1139758 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1642375/000114420417017714/cik0001642375-20161231.xml#145160 Filing: 000114420417017714 Input fundies:CapitalExpenditure: 2162 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1642375/000114420417017714/cik0001642375-20161231.xml#145590 Filing: 000114420417017714 The citation records this snapshot. The page link may show a newer release later.
2016 2016-01-01 – 2016-12-31	−USD 5.75 million Exact value Exact value: -5748397 USD 2016-01-01 – 2016-12-31: -5748397 USD Inspect Net Income Open source Share or cite Citation for Net Income · Guardion Health Sciences, Inc. · 2016-12-31 Guardion Health Sciences, Inc. (edgar:1642375) Net Income: -5748397 USD Concept: fundies:NetIncome Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T18:04:48Z Snapshot: fee39ab9da2ec6e0d64b11ac4212a48b5c028adf2a50ce0efb49b877ab2b1e6a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1642375/explain?concept=fundies%3ANetIncome&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:NetIncome: -5748397 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1642375/000114420418011242/cik0001642375-20171231.xml#103868 Filing: 000114420418011242 The citation records this snapshot. The page link may show a newer release later.	−USD 1.65 million Exact value Exact value: -1653574 USD 2016-01-01 – 2016-12-31: -1653574 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Guardion Health Sciences, Inc. · 2016-12-31 Guardion Health Sciences, Inc. (edgar:1642375) Operating Cash Flow: -1653574 USD Concept: fundies:OperatingCashFlow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T18:04:48Z Snapshot: fee39ab9da2ec6e0d64b11ac4212a48b5c028adf2a50ce0efb49b877ab2b1e6a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1642375/explain?concept=fundies%3AOperatingCashFlow&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1653574 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1642375/000114420418011242/cik0001642375-20171231.xml#109833 Filing: 000114420418011242 The citation records this snapshot. The page link may show a newer release later.	USD 3,354 Exact value Exact value: 3354 USD 2016-01-01 – 2016-12-31: 3354 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Guardion Health Sciences, Inc. · 2016-12-31 Guardion Health Sciences, Inc. (edgar:1642375) Capital Expenditure: 3354 USD Concept: fundies:CapitalExpenditure Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T18:04:48Z Snapshot: fee39ab9da2ec6e0d64b11ac4212a48b5c028adf2a50ce0efb49b877ab2b1e6a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1642375/explain?concept=fundies%3ACapitalExpenditure&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 3354 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1642375/000114420418011242/cik0001642375-20171231.xml#110224 Filing: 000114420418011242 The citation records this snapshot. The page link may show a newer release later.	−USD 1.66 million Calculation and evidence -1653574 − 3354 USD Exact free cash flow: -1656928 USD 2016-01-01 – 2016-12-31: -1653574 USD · Inspect Operating Cash Flow · Source 2016-01-01 – 2016-12-31: 3354 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Guardion Health Sciences, Inc. · 2016-12-31 Guardion Health Sciences, Inc. (edgar:1642375) Free cash flow: -1656928 USD Concept: free-cash-flow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T18:04:48Z Snapshot: fee39ab9da2ec6e0d64b11ac4212a48b5c028adf2a50ce0efb49b877ab2b1e6a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1642375?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -1653574 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1642375/000114420418011242/cik0001642375-20171231.xml#109833 Filing: 000114420418011242 Input fundies:CapitalExpenditure: 3354 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1642375/000114420418011242/cik0001642375-20171231.xml#110224 Filing: 000114420418011242 The citation records this snapshot. The page link may show a newer release later.
2017 2017-01-01 – 2017-12-31	−USD 5.31 million Exact value Exact value: -5305169 USD 2017-01-01 – 2017-12-31: -5305169 USD Inspect Net Income Open source Share or cite Citation for Net Income · Guardion Health Sciences, Inc. · 2017-12-31 Guardion Health Sciences, Inc. (edgar:1642375) Net Income: -5305169 USD Concept: fundies:NetIncome Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T18:04:48Z Snapshot: fee39ab9da2ec6e0d64b11ac4212a48b5c028adf2a50ce0efb49b877ab2b1e6a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1642375/explain?concept=fundies%3ANetIncome&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:NetIncome: -5305169 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1642375/000114420419007374/cik0001642375-20181231.xml#140708 Filing: 000114420419007374 The citation records this snapshot. The page link may show a newer release later.	−USD 3.4 million Exact value Exact value: -3403696 USD 2017-01-01 – 2017-12-31: -3403696 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Guardion Health Sciences, Inc. · 2017-12-31 Guardion Health Sciences, Inc. (edgar:1642375) Operating Cash Flow: -3403696 USD Concept: fundies:OperatingCashFlow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T18:04:48Z Snapshot: fee39ab9da2ec6e0d64b11ac4212a48b5c028adf2a50ce0efb49b877ab2b1e6a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1642375/explain?concept=fundies%3AOperatingCashFlow&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -3403696 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1642375/000114420419007374/cik0001642375-20181231.xml#144939 Filing: 000114420419007374 The citation records this snapshot. The page link may show a newer release later.	USD 37,280 Exact value Exact value: 37280 USD 2017-01-01 – 2017-12-31: 37280 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Guardion Health Sciences, Inc. · 2017-12-31 Guardion Health Sciences, Inc. (edgar:1642375) Capital Expenditure: 37280 USD Concept: fundies:CapitalExpenditure Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T18:04:48Z Snapshot: fee39ab9da2ec6e0d64b11ac4212a48b5c028adf2a50ce0efb49b877ab2b1e6a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1642375/explain?concept=fundies%3ACapitalExpenditure&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 37280 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1642375/000114420419007374/cik0001642375-20181231.xml#145343 Filing: 000114420419007374 The citation records this snapshot. The page link may show a newer release later.	−USD 3.44 million Calculation and evidence -3403696 − 37280 USD Exact free cash flow: -3440976 USD 2017-01-01 – 2017-12-31: -3403696 USD · Inspect Operating Cash Flow · Source 2017-01-01 – 2017-12-31: 37280 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Guardion Health Sciences, Inc. · 2017-12-31 Guardion Health Sciences, Inc. (edgar:1642375) Free cash flow: -3440976 USD Concept: free-cash-flow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T18:04:48Z Snapshot: fee39ab9da2ec6e0d64b11ac4212a48b5c028adf2a50ce0efb49b877ab2b1e6a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1642375?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -3403696 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1642375/000114420419007374/cik0001642375-20181231.xml#144939 Filing: 000114420419007374 Input fundies:CapitalExpenditure: 37280 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1642375/000114420419007374/cik0001642375-20181231.xml#145343 Filing: 000114420419007374 The citation records this snapshot. The page link may show a newer release later.
2018 2018-01-01 – 2018-12-31	−USD 7.77 million Exact value Exact value: -7767407 USD 2018-01-01 – 2018-12-31: -7767407 USD Inspect Net Income Open source Share or cite Citation for Net Income · Guardion Health Sciences, Inc. · 2018-12-31 Guardion Health Sciences, Inc. (edgar:1642375) Net Income: -7767407 USD Concept: fundies:NetIncome Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T18:04:48Z Snapshot: fee39ab9da2ec6e0d64b11ac4212a48b5c028adf2a50ce0efb49b877ab2b1e6a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1642375/explain?concept=fundies%3ANetIncome&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:NetIncome: -7767407 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1642375/000149315220005000/ghsi-20191231.xml#155890 Filing: 000149315220005000 The citation records this snapshot. The page link may show a newer release later.	−USD 4.17 million Exact value Exact value: -4173831 USD 2018-01-01 – 2018-12-31: -4173831 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Guardion Health Sciences, Inc. · 2018-12-31 Guardion Health Sciences, Inc. (edgar:1642375) Operating Cash Flow: -4173831 USD Concept: fundies:OperatingCashFlow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T18:04:48Z Snapshot: fee39ab9da2ec6e0d64b11ac4212a48b5c028adf2a50ce0efb49b877ab2b1e6a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1642375/explain?concept=fundies%3AOperatingCashFlow&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -4173831 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1642375/000149315220005000/ghsi-20191231.xml#170799 Filing: 000149315220005000 The citation records this snapshot. The page link may show a newer release later.	USD 260,243 Exact value Exact value: 260243 USD 2018-01-01 – 2018-12-31: 260243 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Guardion Health Sciences, Inc. · 2018-12-31 Guardion Health Sciences, Inc. (edgar:1642375) Capital Expenditure: 260243 USD Concept: fundies:CapitalExpenditure Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T18:04:48Z Snapshot: fee39ab9da2ec6e0d64b11ac4212a48b5c028adf2a50ce0efb49b877ab2b1e6a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1642375/explain?concept=fundies%3ACapitalExpenditure&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 260243 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1642375/000149315220005000/ghsi-20191231.xml#171167 Filing: 000149315220005000 The citation records this snapshot. The page link may show a newer release later.	−USD 4.43 million Calculation and evidence -4173831 − 260243 USD Exact free cash flow: -4434074 USD 2018-01-01 – 2018-12-31: -4173831 USD · Inspect Operating Cash Flow · Source 2018-01-01 – 2018-12-31: 260243 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Guardion Health Sciences, Inc. · 2018-12-31 Guardion Health Sciences, Inc. (edgar:1642375) Free cash flow: -4434074 USD Concept: free-cash-flow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T18:04:48Z Snapshot: fee39ab9da2ec6e0d64b11ac4212a48b5c028adf2a50ce0efb49b877ab2b1e6a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1642375?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -4173831 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1642375/000149315220005000/ghsi-20191231.xml#170799 Filing: 000149315220005000 Input fundies:CapitalExpenditure: 260243 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1642375/000149315220005000/ghsi-20191231.xml#171167 Filing: 000149315220005000 The citation records this snapshot. The page link may show a newer release later.
2019 2019-01-01 – 2019-12-31	−USD 10.88 million Exact value Exact value: -10878308 USD 2019-01-01 – 2019-12-31: -10878308 USD Inspect Net Income Open source Share or cite Citation for Net Income · Guardion Health Sciences, Inc. · 2019-12-31 Guardion Health Sciences, Inc. (edgar:1642375) Net Income: -10878308 USD Concept: fundies:NetIncome Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T18:04:48Z Snapshot: fee39ab9da2ec6e0d64b11ac4212a48b5c028adf2a50ce0efb49b877ab2b1e6a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1642375/explain?concept=fundies%3ANetIncome&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:NetIncome: -10878308 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1642375/000149315221006883/ghsi-20201231.xml#158010 Filing: 000149315221006883 The citation records this snapshot. The page link may show a newer release later.	−USD 6.03 million Exact value Exact value: -6030004 USD 2019-01-01 – 2019-12-31: -6030004 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Guardion Health Sciences, Inc. · 2019-12-31 Guardion Health Sciences, Inc. (edgar:1642375) Operating Cash Flow: -6030004 USD Concept: fundies:OperatingCashFlow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T18:04:48Z Snapshot: fee39ab9da2ec6e0d64b11ac4212a48b5c028adf2a50ce0efb49b877ab2b1e6a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1642375/explain?concept=fundies%3AOperatingCashFlow&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -6030004 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1642375/000149315221006883/ghsi-20201231.xml#265081 Filing: 000149315221006883 The citation records this snapshot. The page link may show a newer release later.	USD 171,076 Exact value Exact value: 171076 USD 2019-01-01 – 2019-12-31: 171076 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Guardion Health Sciences, Inc. · 2019-12-31 Guardion Health Sciences, Inc. (edgar:1642375) Capital Expenditure: 171076 USD Concept: fundies:CapitalExpenditure Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T18:04:48Z Snapshot: fee39ab9da2ec6e0d64b11ac4212a48b5c028adf2a50ce0efb49b877ab2b1e6a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1642375/explain?concept=fundies%3ACapitalExpenditure&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 171076 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1642375/000149315221006883/ghsi-20201231.xml#265448 Filing: 000149315221006883 The citation records this snapshot. The page link may show a newer release later.	−USD 6.2 million Calculation and evidence -6030004 − 171076 USD Exact free cash flow: -6201080 USD 2019-01-01 – 2019-12-31: -6030004 USD · Inspect Operating Cash Flow · Source 2019-01-01 – 2019-12-31: 171076 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Guardion Health Sciences, Inc. · 2019-12-31 Guardion Health Sciences, Inc. (edgar:1642375) Free cash flow: -6201080 USD Concept: free-cash-flow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T18:04:48Z Snapshot: fee39ab9da2ec6e0d64b11ac4212a48b5c028adf2a50ce0efb49b877ab2b1e6a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1642375?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -6030004 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1642375/000149315221006883/ghsi-20201231.xml#265081 Filing: 000149315221006883 Input fundies:CapitalExpenditure: 171076 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1642375/000149315221006883/ghsi-20201231.xml#265448 Filing: 000149315221006883 The citation records this snapshot. The page link may show a newer release later.
2020 2020-01-01 – 2020-12-31	−USD 8.57 million Exact value Exact value: -8571657 USD 2020-01-01 – 2020-12-31: -8571657 USD Inspect Net Income Open source Share or cite Citation for Net Income · Guardion Health Sciences, Inc. · 2020-12-31 Guardion Health Sciences, Inc. (edgar:1642375) Net Income: -8571657 USD Concept: fundies:NetIncome Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T18:04:48Z Snapshot: fee39ab9da2ec6e0d64b11ac4212a48b5c028adf2a50ce0efb49b877ab2b1e6a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1642375/explain?concept=fundies%3ANetIncome&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:NetIncome: -8571657 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1642375/000149315222008581/form10-k.htm#974541 Filing: 000149315222008581 The citation records this snapshot. The page link may show a newer release later.	−USD 8.01 million Exact value Exact value: -8013929 USD 2020-01-01 – 2020-12-31: -8013929 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Guardion Health Sciences, Inc. · 2020-12-31 Guardion Health Sciences, Inc. (edgar:1642375) Operating Cash Flow: -8013929 USD Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T18:04:48Z Snapshot: fee39ab9da2ec6e0d64b11ac4212a48b5c028adf2a50ce0efb49b877ab2b1e6a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1642375/explain?concept=fundies%3AOperatingCashFlow&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -8013929 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1642375/000149315222008581/form10-k.htm#996491 Filing: 000149315222008581 The citation records this snapshot. The page link may show a newer release later.	USD 40,733 Exact value Exact value: 40733 USD 2020-01-01 – 2020-12-31: 40733 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Guardion Health Sciences, Inc. · 2020-12-31 Guardion Health Sciences, Inc. (edgar:1642375) Capital Expenditure: 40733 USD Concept: fundies:CapitalExpenditure Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T18:04:48Z Snapshot: fee39ab9da2ec6e0d64b11ac4212a48b5c028adf2a50ce0efb49b877ab2b1e6a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1642375/explain?concept=fundies%3ACapitalExpenditure&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 40733 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1642375/000149315222008581/form10-k.htm#998878 Filing: 000149315222008581 The citation records this snapshot. The page link may show a newer release later.	−USD 8.05 million Calculation and evidence -8013929 − 40733 USD Exact free cash flow: -8054662 USD 2020-01-01 – 2020-12-31: -8013929 USD · Inspect Operating Cash Flow · Source 2020-01-01 – 2020-12-31: 40733 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Guardion Health Sciences, Inc. · 2020-12-31 Guardion Health Sciences, Inc. (edgar:1642375) Free cash flow: -8054662 USD Concept: free-cash-flow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T18:04:48Z Snapshot: fee39ab9da2ec6e0d64b11ac4212a48b5c028adf2a50ce0efb49b877ab2b1e6a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1642375?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -8013929 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1642375/000149315222008581/form10-k.htm#996491 Filing: 000149315222008581 Input fundies:CapitalExpenditure: 40733 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1642375/000149315222008581/form10-k.htm#998878 Filing: 000149315222008581 The citation records this snapshot. The page link may show a newer release later.
2021 2021-01-01 – 2021-12-31	−USD 24.75 million Exact value Exact value: -24745009 USD 2021-01-01 – 2021-12-31: -24745009 USD Inspect Net Income Open source Share or cite Citation for Net Income · Guardion Health Sciences, Inc. · 2021-12-31 Guardion Health Sciences, Inc. (edgar:1642375) Net Income: -24745009 USD Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T18:04:48Z Snapshot: fee39ab9da2ec6e0d64b11ac4212a48b5c028adf2a50ce0efb49b877ab2b1e6a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1642375/explain?concept=fundies%3ANetIncome&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:NetIncome: -24745009 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1642375/000149315223012449/form10-k.htm#1095777 Filing: 000149315223012449 The citation records this snapshot. The page link may show a newer release later.	−USD 10.64 million Exact value Exact value: -10644416 USD 2021-01-01 – 2021-12-31: -10644416 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Guardion Health Sciences, Inc. · 2021-12-31 Guardion Health Sciences, Inc. (edgar:1642375) Operating Cash Flow: -10644416 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T18:04:48Z Snapshot: fee39ab9da2ec6e0d64b11ac4212a48b5c028adf2a50ce0efb49b877ab2b1e6a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1642375/explain?concept=fundies%3AOperatingCashFlow&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -10644416 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1642375/000149315223012449/form10-k.htm#1114835 Filing: 000149315223012449 The citation records this snapshot. The page link may show a newer release later.	USD 74,592 Exact value Exact value: 74592 USD 2021-01-01 – 2021-12-31: 74592 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Guardion Health Sciences, Inc. · 2021-12-31 Guardion Health Sciences, Inc. (edgar:1642375) Capital Expenditure: 74592 USD Concept: fundies:CapitalExpenditure Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T18:04:48Z Snapshot: fee39ab9da2ec6e0d64b11ac4212a48b5c028adf2a50ce0efb49b877ab2b1e6a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1642375/explain?concept=fundies%3ACapitalExpenditure&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 74592 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1642375/000149315223012449/form10-k.htm#1116691 Filing: 000149315223012449 The citation records this snapshot. The page link may show a newer release later.	−USD 10.72 million Calculation and evidence -10644416 − 74592 USD Exact free cash flow: -10719008 USD 2021-01-01 – 2021-12-31: -10644416 USD · Inspect Operating Cash Flow · Source 2021-01-01 – 2021-12-31: 74592 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Guardion Health Sciences, Inc. · 2021-12-31 Guardion Health Sciences, Inc. (edgar:1642375) Free cash flow: -10719008 USD Concept: free-cash-flow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T18:04:48Z Snapshot: fee39ab9da2ec6e0d64b11ac4212a48b5c028adf2a50ce0efb49b877ab2b1e6a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1642375?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -10644416 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1642375/000149315223012449/form10-k.htm#1114835 Filing: 000149315223012449 Input fundies:CapitalExpenditure: 74592 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1642375/000149315223012449/form10-k.htm#1116691 Filing: 000149315223012449 The citation records this snapshot. The page link may show a newer release later.
2022 2022-01-01 – 2022-12-31	−USD 14.92 million Exact value Exact value: -14922228 USD 2022-01-01 – 2022-12-31: -14922228 USD Inspect Net Income Open source Share or cite Citation for Net Income · Guardion Health Sciences, Inc. · 2022-12-31 Guardion Health Sciences, Inc. (edgar:1642375) Net Income: -14922228 USD Concept: fundies:NetIncome Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T18:04:48Z Snapshot: fee39ab9da2ec6e0d64b11ac4212a48b5c028adf2a50ce0efb49b877ab2b1e6a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1642375/explain?concept=fundies%3ANetIncome&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:NetIncome: -14922228 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1642375/000149315224011813/form10-k.htm#947836 Filing: 000149315224011813 The citation records this snapshot. The page link may show a newer release later.	−USD 7.45 million Exact value Exact value: -7446812 USD 2022-01-01 – 2022-12-31: -7446812 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Guardion Health Sciences, Inc. · 2022-12-31 Guardion Health Sciences, Inc. (edgar:1642375) Operating Cash Flow: -7446812 USD Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T18:04:48Z Snapshot: fee39ab9da2ec6e0d64b11ac4212a48b5c028adf2a50ce0efb49b877ab2b1e6a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1642375/explain?concept=fundies%3AOperatingCashFlow&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -7446812 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1642375/000149315224011813/form10-k.htm#990003 Filing: 000149315224011813 The citation records this snapshot. The page link may show a newer release later.	USD 5,569 Exact value Exact value: 5569 USD 2022-01-01 – 2022-12-31: 5569 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Guardion Health Sciences, Inc. · 2022-12-31 Guardion Health Sciences, Inc. (edgar:1642375) Capital Expenditure: 5569 USD Concept: fundies:CapitalExpenditure Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T18:04:48Z Snapshot: fee39ab9da2ec6e0d64b11ac4212a48b5c028adf2a50ce0efb49b877ab2b1e6a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1642375/explain?concept=fundies%3ACapitalExpenditure&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 5569 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1642375/000149315224011813/form10-k.htm#995360 Filing: 000149315224011813 The citation records this snapshot. The page link may show a newer release later.	−USD 7.45 million Calculation and evidence -7446812 − 5569 USD Exact free cash flow: -7452381 USD 2022-01-01 – 2022-12-31: -7446812 USD · Inspect Operating Cash Flow · Source 2022-01-01 – 2022-12-31: 5569 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Guardion Health Sciences, Inc. · 2022-12-31 Guardion Health Sciences, Inc. (edgar:1642375) Free cash flow: -7452381 USD Concept: free-cash-flow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T18:04:48Z Snapshot: fee39ab9da2ec6e0d64b11ac4212a48b5c028adf2a50ce0efb49b877ab2b1e6a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1642375?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -7446812 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1642375/000149315224011813/form10-k.htm#990003 Filing: 000149315224011813 Input fundies:CapitalExpenditure: 5569 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1642375/000149315224011813/form10-k.htm#995360 Filing: 000149315224011813 The citation records this snapshot. The page link may show a newer release later.
2023 2023-01-01 – 2023-12-31	USD 158,033 Exact value Exact value: 158033 USD 2023-01-01 – 2023-12-31: 158033 USD Inspect Net Income Open source Share or cite Citation for Net Income · Guardion Health Sciences, Inc. · 2023-12-31 Guardion Health Sciences, Inc. (edgar:1642375) Net Income: 158033 USD Concept: fundies:NetIncome Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T18:04:48Z Snapshot: fee39ab9da2ec6e0d64b11ac4212a48b5c028adf2a50ce0efb49b877ab2b1e6a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1642375/explain?concept=fundies%3ANetIncome&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:NetIncome: 158033 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1642375/000149315224011813/form10-k.htm#946982 Filing: 000149315224011813 The citation records this snapshot. The page link may show a newer release later.	−USD 4.37 million Exact value Exact value: -4369885 USD 2023-01-01 – 2023-12-31: -4369885 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Guardion Health Sciences, Inc. · 2023-12-31 Guardion Health Sciences, Inc. (edgar:1642375) Operating Cash Flow: -4369885 USD Concept: fundies:OperatingCashFlow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T18:04:48Z Snapshot: fee39ab9da2ec6e0d64b11ac4212a48b5c028adf2a50ce0efb49b877ab2b1e6a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1642375/explain?concept=fundies%3AOperatingCashFlow&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -4369885 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1642375/000149315224011813/form10-k.htm#1053391 Filing: 000149315224011813 The citation records this snapshot. The page link may show a newer release later.	USD 3,792 Exact value Exact value: 3792 USD 2023-01-01 – 2023-12-31: 3792 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Guardion Health Sciences, Inc. · 2023-12-31 Guardion Health Sciences, Inc. (edgar:1642375) Capital Expenditure: 3792 USD Concept: fundies:CapitalExpenditure Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T18:04:48Z Snapshot: fee39ab9da2ec6e0d64b11ac4212a48b5c028adf2a50ce0efb49b877ab2b1e6a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1642375/explain?concept=fundies%3ACapitalExpenditure&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 3792 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1642375/000149315224011813/form10-k.htm#994524 Filing: 000149315224011813 The citation records this snapshot. The page link may show a newer release later.	−USD 4.37 million Calculation and evidence -4369885 − 3792 USD Exact free cash flow: -4373677 USD 2023-01-01 – 2023-12-31: -4369885 USD · Inspect Operating Cash Flow · Source 2023-01-01 – 2023-12-31: 3792 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Guardion Health Sciences, Inc. · 2023-12-31 Guardion Health Sciences, Inc. (edgar:1642375) Free cash flow: -4373677 USD Concept: free-cash-flow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T18:04:48Z Snapshot: fee39ab9da2ec6e0d64b11ac4212a48b5c028adf2a50ce0efb49b877ab2b1e6a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1642375?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -4369885 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1642375/000149315224011813/form10-k.htm#1053391 Filing: 000149315224011813 Input fundies:CapitalExpenditure: 3792 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1642375/000149315224011813/form10-k.htm#994524 Filing: 000149315224011813 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

44 filings · 2,543 latest values · 2,543 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001642375, 1642375, GHSI, edgar:1642375

Also known as GUARDION HEALTH SCIENCES, INC., GUARDION HEALTH SCIENCES, INC., Guardion Health Sciences, Inc., Guardion Health Sciences, LLC

Guardion Health Sciences, Inc.

Latest quarter

Revenue

Operating margin

Operating cash flow

Reported share-count change

Trailing twelve months

Revenue

Net income

Operating cash flow

Capital expenditure

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2023 2023-01-01 – 2023-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation